Related Experiment Videos
Fungal infections in iatrogenically compromised hosts
J H Rex1, T J Walsh, E J Anaissie
1Department of Internal Medicine, University of Texas Medical School, Houston, USA.
Advances in Internal Medicine
|March 20, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Addressing the dual-use of antifungals and fungal antimicrobial resistance (fAMR) through a One Health approach.
npj antimicrobials and resistance·2026
In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis.
Antimicrobial agents and chemotherapy·2021
Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Antimicrobial agents and chemotherapy·2019
Efficacy of Olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease.
Antimicrobial agents and chemotherapy·2019
The challenge of antimicrobial resistance: new regulatory tools to support product development.
Clinical pharmacology and therapeutics·2014
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
Transplant infectious disease : an official journal of the Transplantation Society·2014
A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
Advances in internal medicine·2002
Pathogenesis and treatment of cardiomyopathy.
Advances in internal medicine·2002
Update on the prevention, diagnosis, and treatment of Lyme disease.
Advances in internal medicine·2001
Impact of stroke on respiratory function and amyloid-β pathology in Tg-2576 mice.
Journal of Alzheimer's disease : JAD·2026
In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207.
Chemical research in toxicology·2026
TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026